Veri MedTech Holdings, Inc. (VRHI) Stock Concentration Calculator

Calculator · free · no signup · VRHI

Quantify Veri MedTech Holdings, Inc. concentration risk. Drawdown impact at 30 / 50 / 70%, with the trade-off between selling down and hedging — tax-aware.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

Your inputs

Adjust — results update instantly.

Position & portfolio

Default. Adjust to test.
35%
10%

Tax

67%
Highly concentratedLong-term
If 30% drop
−$150,000
If 50% drop
−$250,000
If 70% drop
−$350,000

Most fee-only advisors target ≤10% in any single name. You're at 67%.

Estimates only. Not financial advice.

Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$195,376).

Cost of fully de-concentrating

All three plans sell to 0% (no hedge).

Tax
Wealth (3y)$972,590
+$49,522 vs.

Tax
Wealth (3y)$1M
+$106,695 vs.

Tax
Wealth (3y)$1.1M
+$172,106 vs.

Build your own plan

Toggle below — chart updates live. Sell buttons show the slice.
Sell over 1 yearSell over 2 yearsSell over 3 yearsCustom
$712,500$841,272$970,043$1,098,815$1,227,587Yr 0Yr 1Yr 2Yr 3
Year 1
Year 2
Year 3
Tax$253,180
Hedge cost$38,908
Wealth at Y3$1,141,624
Vs. best fixed plan+$46,450

Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.

Tax brackets: 2026 · Estimates only — not financial advice.

Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.

About Veri MedTech Holdings, Inc.

Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company.

OTC; cannabis telehealth.

Equity grants at Veri MedTech Holdings, Inc. typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).

Joshua Green and Samuel Adetunji founded Veriheal in McLean, Virginia in 2017 to connect patients with state-licensed physicians for medical marijuana card services. The parent holding company, Veri MedTech Holdings, Inc., reported roughly $22 million in revenue in 2023 and $17 million in 2024. The company trades on the OTC market under ticker VRHI and is pursuing a $15 million Nasdaq uplisting at $4 per share, though auditors have flagged going-concern uncertainty pending the additional capital.

Sources: stocktitan.net · businessofcannabis.com

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Veri MedTech Holdings, Inc..

Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company. OTC; cannabis telehealth. If a meaningful share of your net worth sits in VRHI, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) and hedging (option premium drag) — auto-filled with VRHI's option-implied volatility.

All Veri MedTech Holdings, Inc. tools → · Use the generic Stock Concentration Calculator for any company.

Find another companyVertical SaaS peers

One piece of the puzzle.

OptionsAhoy plans your Veri MedTech Holdings, Inc. equity alongside hedging, vesting, and de-concentration — across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access